No Data
Johnson & Johnson Commemorates 50 Years in Singapore With a Series of Events Marking a Remarkable Milestone
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating
Citi analyst Joanne Wuensch maintains $Johnson & Johnson(JNJ.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 63.8% and a total average return of 6.4% over the
Johnson & Johnson (JNJ) Faces Legal Challenges While Advancing MedTech Innovations for Growth
U.S. To J&J: Don't Target Hospital Drug Discounts -- WSJ
Sector Update: Health Care Stocks Steady Premarket Tuesday